La chaîne d'options affiche les données clés des options sur actions de Clearside Biomedical à différents prix d'exercice et dates d'expiration. Les traders utilisent ces informations pour analyser les transactions potentielles et évaluer le sentiment du marché pour Clearside Biomedical..

Clearside Biomedical (NASDAQ:CLSD) Stock, Chaîne d'Options

CLEARSIDE BIOMEDICAL INC

Clearside Biomedical

Clearside Biomedical Inc is a United States-based clinical biopharmaceutical company. It is engaged in developing pharmacological therapies to treat blinding disease of the eye through the suprachoroidal space, or SCS. The company's novel SCS injection platform, utilizing a proprietary SCS Microinjector, enables an in-office, repeatable, non-surgical procedure for the targeted and compartmentalized delivery of a wide variety of therapies to the macula, retina, or choroid to potentially preserve and improve vision in patients with sight-threatening eye diseases.

<a href="https://www.wsj.com/business/hospitality/mcdonalds-snack-wraps-lettuce-shortage-7067d573" title="https://www.wsj.com/business/hospitality/mcdonalds-snack-wraps-lettuce-shortage-7067d573">https://www.wsj.com/business/hospitality/mcdonalds-snack-wraps-lettuce-shortage-7067d573</a>

News

'McDonald's Snack Wrap Rollout Leads to Lettuce Crunch' - WSJ Exclusive

WIIM

Vistra shares are trading higher amid momentum in nuclear-linked names.

<ul>
<li>Raj Jegannathan takes over Tesla sales amid declining demand</li>
<li>The IT exec lacks traditional sales experience, has grown closer to Elon Musk</li>
<li>High-level departures at Tesla include Troy Jones, Omead Afshar</li>
</ul>
July 18 (Reuters) - A relatively little-known information technology executive is running Tesla's <a href="https://workspace.refinitiv.com/web/apps/quotewebapi?RIC=TSLA.O">TSLA.O</a> sales team as the electric carmaker grapples with a sales freefall, according to people familiar with the matter.
Raj Jegannathan, a senior executive with a wide purview including several IT and data functions, recently took over the sales role, said the people familiar with the matter. Some inside Tesla have interpreted this to mean that Jegannathan has assumed the role of Troy Jones, Tesla's top sales executive in North America until he departed earlier this month after 15 years with the company, said the people.
Jegannathan, who has recently grown closer to CEO Elon Musk, has no traditional sales experience, according to two people familiar with the matter and his LinkedIn profile. Reuters could not determine if it is an interim role.
Demand for Tesla's cars in Europe and North America has dropped sharply. Last quarter, its <a href="reuters://REALTIME/verb=NewsStory/ric=nL3N3QE0I5">quarterly sales plunged 13%</a> to the weakest in nearly three years, due to a backlash to Musk's politics, Tesla's aging vehicle lineup and increased competition from rivals offering more affordable alternatives.
Tesla did not immediately respond to a request for comment.
Jones, the latest in a string of high-level departures, managed the fallout as Musk's political affiliation with U.S. President Trump prompted left-leaning consumers to shun Tesla.
As Tesla's sales were dropping earlier this year, Jones implored managers to work on selling and pushed back against concerns over political headwinds related to Musk, according to a person who heard the comment.
Other key figures who recently left include <a href="https://www.bing.com/search?pglt=2083&amp;q=Omead+Afshar+tesla+reuters&amp;cvid=805c1f441daf4e5f802fcb8e4c518bda&amp;gs_lcrp=EgRlZGdlKgYIABBFGDkyBggAEEUYOTIICAEQ6QcY_FXSAQg4MDAxajBqMagCALACAA&amp;FORM=ANNAB1&amp;PC=U531">Musk's confidant Omead Afshar</a>, who was in charge of sales and manufacturing operations in North America and Europe. Jegannathan's expanded role has been interpreted as taking over Afshar's responsibilities as well, some of the people said.
Milan Kovac, the head of Tesla's Optimus humanoid robot team, announced he was leaving in June. Other recent departures include top battery executive Vineet Mehta and software chief David Lau. Last year, Tesla faced a wave of high-level departures, including chief battery engineer Drew Baglino and global public policy head Rohan Patel.
Jegannathan has spent 13 years at Tesla in technology roles. He joined in 2012 as a senior staff engineer, with responsibilities for internet traffic and cloud security, according to his LinkedIn page. More recently, he has helped develop Tesla's data center effort in Texas, two people familiar with the matter said.
His duties have expanded rapidly. Earlier this year, he became a vice president for IT/AI infrastructure, apps and information security, according to his LinkedIn page. In recent months, he has taken over Tesla's vehicle-service operations, according to a person familiar with the matter and Jegannathan's comments on X.
Jegannathan was among the Tesla employees seconded to Twitter after Musk's takeover of the company in 2022, according to a person familiar with the matter and a media report.
&nbsp;

TSLA

'Tesla Elevates It Executive Without Traditional Car Sales Experience To Run Sales, Sources Say' - Reuters Exclusive

CIBC maintains RB Global (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RBA#NYSE">RBA</a>) with a Outperformer and raises the price target from $118 to $121.

Price Target

Analyst Ratings

CIBC Maintains Outperformer on RB Global, Raises Price Target to $121

Shares of business intelligence firm and major Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) holder MicroStrategy Inc Class A (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSTR#NASDAQ">MSTR</a>) are trading lower Friday afternoon, bucking the broader optimism sweeping the cryptocurrency sector. 
After opening the session flat, MSTR stock was trading down approximately 6% by Friday afternoon, even as the digital asset industry celebrated a <a href="https://www.benzinga.com/crypto/25/07/46480331/the-us-just-took-a-big-step-toward-crypto-regulation-heres-what-the-clarity-act-actually-says">major legislative victory</a>.
What To Know: On Thursday, the U.S. House of Representatives passed the CLARITY Act, a comprehensive bill aimed at providing a clear regulatory framework for digital assets. The legislation delineates oversight authority between the SEC and the CFTC, a move hailed by industry leaders as a "<a href="https://www.benzinga.com/crypto/25/07/46480331/the-us-just-took-a-big-step-toward-crypto-regulation-heres-what-the-clarity-act-actually-says">milestone for American innovation</a>." 
The bill, which now heads to the Senate, is seen as a foundational step toward legitimizing and integrating blockchain technologies into the U.S. financial system.
This development follows the passage of the GENIUS Act, or stablecoin bill, which is expected to be signed into law and could unlock trillions in market growth. Leaders from Ripple and Coinbase Global Inc lauded the legislative progress as &#8220;<a href="https://www.benzinga.com/crypto/cryptocurrency/25/07/46487109/ripple-ceo-hails-genius-act-as-transformational-legislation-compares-it-to-dodd-frank-act-this-moment-is-a-historic-one">transformational</a>&#8221; for the industry.
However, the positive regulatory momentum failed to lift MicroStrategy, the largest corporate holder of Bitcoin. The stock's decline suggests that despite the favorable long-term outlook for crypto, immediate market pressures or broader profit-taking may be weighing on the heavily-leveraged Bitcoin proxy.
Benzinga Edge Rankings: According to <a href="http://benzinga.grsm.io/register174">Benzinga Edge</a> stock rankings, which measure stocks across four critical factors, MicroStrategy presents a starkly mixed profile. The company boasts an exceptional Momentum score of 96.54, indicating its stock has experienced extremely strong price appreciation recently. 
However, this is contrasted by very low scores in other fundamental areas. MSTR receives a Value score of just 3.23 and a Growth score of 3.11, suggesting that the stock is perceived as overvalued and that its underlying business growth is weak. 
This profile paints a picture of a high-momentum stock whose market performance is detached from traditional value and growth metrics.
Price Action: According to data from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>, MSTR shares are trading lower by $424.34 Friday afternoon. The stock has a 52-week high of $542.99 and a 52-week low of $102.40.
Read Also: <a href="https://www.benzinga.com/crypto/cryptocurrency/25/07/46494778/67m-for-more-eth-bit-digital-expands-its-ethereum-treasury-beyond-120000-coins">$67M For More ETH: Bit Digital Expands Its Ethereum Treasury Beyond 120,000 Coins</a>
<h2 class="wp-block-heading">How To Buy MSTR Stock</h2>
Besides going to a brokerage platform to purchase a share &#8211; or fractional share &#8211; of stock, you can also gain access to shares either by buying an exchange traded fund (ETF) that holds the stock itself, or by allocating yourself to a strategy in your 401(k) that would seek to acquire shares in a mutual fund or other instrument. 
For example, in Strategy&#8217;s case, it is in the Information Technology sector. An ETF will likely hold shares in many liquid and large companies that help track that sector, allowing an investor to gain exposure to the trends within that segment.
Image: Shutterstock

$BTC

MSTR

MicroStrategy (MSTR) Stock Slides 5% Despite Landmark Crypto Legislation

CIBC analyst Jacob Bout maintains Stantec (TSX:<a class="ticker" href="https://www.benzinga.com/stock/STN#TSX">STN</a>) with a Outperformer and raises the price target from C$156 to C$168.

TSX:STN

CIBC Maintains Outperformer on Stantec, Raises Price Target to C$168

Shares of Humana Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HUM#NYSE">HUM</a>) are trading lower Friday after the company lost a legal battle over Medicare bonus payments. 
What To Know: A Texas district court dismissed Humana's lawsuit, upholding the government's decision to downgrade the company's Medicare quality ratings. The ruling is expected to reduce Humana's Medicare bonus payments beginning in 2026, posing a risk to future profitability. Following the court's decision, Humana shares dropped as much as 7.5% earlier in the session before settling lower, <a href="https://www.bloomberg.com/news/articles/2025-07-18/humana-loses-bid-to-reverse-medicare-bonus-payment-cut?embedded-checkout=true">according to Bloomberg.</a>
The ruling adds to growing scrutiny of the private health insurance industry, particularly concerning claim denials. Recent data compiled by Komodo Health for <a href="https://www.nytimes.com/2025/07/18/health/health-insurance-prescription-claim-denials.html#:~:text=Prescription%20drug%20denials%20by%20private,nation's%20private%20health%20insurance%20system.">The New York Time</a>s revealed a 25% increase in prescription drug denials by private insurers between 2016 and 2023. 
Humana's denial rates reportedly declined in the last two years of the study period but the industry as a whole saw higher rejection rates.
HUM Price Action: Humana shares were down 1.66% at $219.85 at the time of writing, according to<a href="https://pro.benzinga.com/dashboard"> Benzinga Pro.</a>
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/equities/25/07/46499876/wall-street-friday-stocks-today-trump-netflix-earnings">Stocks Slip As Netflix Fails To Impress, Bitcoin Eyes Negative Week: What&#8217;s Moving Markets Friday?</a></li>
</ul>
Image Via Shutterstock.

Movers

Humana Shares Decline After Losing Medicare Bonus Payment Lawsuit: What To Know

Talen Energy Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLN#NASDAQ">TLN</a>) shares are trading higher Friday after the company announced it signed definitive agreements to acquire two major <a href="https://www.benzinga.com/pressreleases/25/07/g46480014/talen-energy-expands-and-enhances-portfolio-with-best-in-class-ccgt-acquisitions-in-pjm">natural gas-fired power plants. </a>
What To Know: The deals include the purchase of Caithness Energy's Moxie Freedom Energy Center in Pennsylvania and Caithness Energy and BlackRock's Guernsey Power Station in Ohio. Both facilities are combined-cycle gas turbine plants located within the PJM power market, one of the largest electricity markets in the United States.
The total gross acquisition price is approximately $3.8 billion, with a net price of $3.5 billion after factoring in expected tax benefits. Talen said the purchase reflects an acquisition multiple of 6.7 times 2026 enterprise value to EBITDA, which the company considers favorable compared to the cost of constructing new combined-cycle plants. The company expects the acquisition to be immediately accretive to free cash flow per share, projecting a gain of over 40% in 2026 and more than 50% through 2029.
According to Talen's CEO Mac McFarland, the deal strengthens the company's generation portfolio by adding modern, highly efficient baseload capacity, boosting annual generation by 50% from around 40 terawatt-hours to approximately 60 terawatt-hours. The plants benefit from access to natural gas infrastructure tied to the Marcellus and Utica shale regions, known for abundant supply and strong pipeline connections.
Talen highlighted the strategic value of the acquisitions for expanding its position in the data center and large-load energy markets. The new assets are expected to enhance the company's ability to deliver reliable, low-carbon power for high-demand sectors requiring consistent energy supply.
To finance the deal, Talen plans to issue roughly<a href="https://www.benzinga.com/pressreleases/25/05/b45434672/five-point-infrastructure-announces-the-formation-of-powerbridge-with-a-1-billion-equity-commitmen"> $3.8 billion in new debt</a>, using both secured and unsecured instruments. The company stated it remains committed to maintaining balance sheet discipline, aiming for a leverage target of 3.5 times or lower by the end of 2026. The acquisitions are expected to close in the fourth quarter of 2025, pending regulatory approvals, including clearance from the Federal Energy Regulatory Commission.
The company also announced it will report its second quarter 2025 financial results on Aug. 7, with management set to hold an earnings call that morning. The acquisitions and the projected financial benefits appear to have driven strong investor interest, leading to Wednesday's significant stock price increase.
TLN Price Action: Talen Energy shares were up 13.6% at $300.00 at the time of writing, according to <a href="https://pro.benzinga.com/dashboard?new_user=False&amp;backend=google-oauth2">Benzinga Pro.</a>
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/equities/25/07/46499876/wall-street-friday-stocks-today-trump-netflix-earnings">Stocks Slip As Netflix Fails To Impress, Bitcoin Eyes Negative Week: What&#8217;s Moving Markets Friday?</a></li>
</ul>
Image Via Shutterstock.

What's Going On With Talen Energy Shares Today?

CIBC analyst Dennis Fong maintains Cenovus Energy (TSX:<a class="ticker" href="https://www.benzinga.com/stock/CVE#TSX">CVE</a>) with a Outperformer and raises the price target from C$28 to C$30.

TSX:CVE

CIBC Maintains Outperformer on Cenovus Energy, Raises Price Target to C$30

CIBC analyst Todd Coupland maintains Shopify (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SHOP#NASDAQ">SHOP</a>) with a Outperformer and raises the price target from $125 to $145.

SHOP

CIBC Maintains Outperformer on Shopify, Raises Price Target to $145

CoreWeave Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRWV#NASDAQ">CRWV</a>) shares are trading lower Friday, possibly amid ongoing pressure following a bearish initiation report from HSBC on Friday.
What To Know: The decline follows HSBC&#8217;s recent initiation of coverage on CoreWeave with a Reduce rating and a price target of $32, signaling an expected downside of more than 70% from the previous closing price.
HSBC analyst Abhishek Shukla expressed concerns about CoreWeave's reliance on a limited customer base, which the firm believes weakens the company's business model. <a href="https://www.cnbc.com/2025/07/17/hsbc-says-coreweave-shares-will-drop-more-than-70percent-on-concerns-about-customer-base.html">According to CNBC</a> a significant portion of CoreWeave's revenue is concentrated among a few clients, most notably Microsoft, OpenAI and Nvidia. These customers reportedly do not utilize CoreWeave's software services, which the analyst argues undermines the company&#8217;s value proposition and limits customer retention advantages.
Shukla noted that in the first quarter of 2025, Microsoft accounted for 72% of CoreWeave's revenue, with Microsoft and OpenAI together making up the majority of the company's backlog. HSBC also warned that the stock appears overvalued after its rapid rise of more than 240% since its public debut in March 2025.
CRWV Price Action: CoreWeave shares were down 7.37% at $122.46 at the time of writing, according to<a href="https://pro.benzinga.com/dashboard?new_user=False&amp;backend=google-oauth2"> Benzinga pro.</a>
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/equities/25/07/46499876/wall-street-friday-stocks-today-trump-netflix-earnings">Stocks Slip As Netflix Fails To Impress, Bitcoin Eyes Negative Week: What&#8217;s Moving Markets Friday?</a></li>
</ul>
Image Via Shutterstock.

CRWV

CoreWeave Shares Slide After HSBC Initiates Coverage With Bearish Outlook

Wells Fargo analyst David Lantz maintains Mister Car Wash (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MCW#NASDAQ">MCW</a>) with a Overweight and lowers the price target from $9 to $8.

Wells Fargo Maintains Overweight on Mister Car Wash, Lowers Price Target to $8

Editor's note: This article has been updated to correct the name of Schwab's CEO.
Charles Schwab (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SCHW#NYSE">SCHW</a>), one of the largest brokerage firms in the United States, has confirmed plans to launch Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) and Ethereum (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>) trading <a href="https://www.benzinga.com/markets/cryptocurrency/25/02/43923960/citadel-securities-moves-into-crypto-market-making-following-trumps-crypto-friendly-regulation-push">services for its retail clients.</a>
What Happened: The announcement was made by Schwab CEO Rick Wurster during a conversation with CNBC on Friday, where he said, &#8220;We also anticipate launching Bitcoin and Ether sometime soon so that our clients have access to that… They really want to bring it back to Schwab because they trust us. They want it to sit alongside their other assets."
Wurster noted that a significant number of Schwab clients currently hold a small portion of their crypto, typically 1–2%, at "digital native firms" but prefer consolidating those assets within Schwab's existing wealth management infrastructure.
The firm expects this product rollout to be a growth driver.
Also Read: <a href="https://www.benzinga.com/crypto/cryptocurrency/25/07/46497183/first-strategy-now-mei-pharma-litecoin-joins-bitcoin-as-treasury-asset">First Strategy, Now MEI Pharma: Litecoin Joins Bitcoin As Treasury Asset</a>
Why It Matters: With this move, Charles Schwab joins a growing list of major brokerages offering direct crypto access:
<ul class="wp-block-list">
<li>Fidelity Investments launched Bitcoin and Ethereum trading for retail investors through its Fidelity Crypto platform in 2023.</li>
<li>Robinhood (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOOD#NASDAQ">HOOD</a>) supports trading for several cryptocurrencies, including BTC, ETH, Dogecoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/doge/usd">DOGE</a>), and Solana (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/sol/usd">SOL</a>), and has been active in crypto custody and wallet products.</li>
<li>Interactive Brokers introduced crypto trading in partnership with Paxos, allowing clients to trade BTC, ETH, Litecoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/ltc/usd">LTC</a>), and BCH directly through its platform since 2021.</li>
<li>E&#x2A;TRADE, owned by Morgan Stanley (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MS#NYSE">MS</a>), began offering Bitcoin and Ethereum trading to select clients via third-party partnerships in 2024.</li>
</ul>
Schwab already has indirect crypto exposure through its participation in EDX Markets, a crypto exchange backed by Fidelity, Citadel Securities, and Virtu Financial. However, the forthcoming launch marks Schwab's first direct retail crypto offering.
The development comes as the U.S. Congress advances the CLARITY Act, landmark legislation passed by the House of Representatives in June.
The Act establishes clearer regulatory boundaries between the SEC and CFTC, creates tailored rules for decentralized networks, and provides a structured framework for token classification. 
The CLARITY Act aims to replace the current patchwork of enforcement with defined compliance pathways, giving traditional financial institutions the confidence to enter the digital asset space <a href="https://www.benzinga.com/crypto/25/07/46480331/the-us-just-took-a-big-step-toward-crypto-regulation-heres-what-the-clarity-act-actually-says">with fewer legal uncertainties.</a>
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/crypto/cryptocurrency/25/07/46494778/67m-for-more-eth-bit-digital-expands-its-ethereum-treasury-beyond-120000-coins">$67M For More ETH: Bit Digital Expands Its Ethereum Treasury Beyond 120,000 Coins</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$DOGE

$ETH

$LTC

$SOL

HOOD

SCHW

Charles Schwab To Launch Bitcoin, Ethereum Trading Services (CORRECTED)

Wells Fargo analyst David Lantz maintains Carvana (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVNA#NYSE">CVNA</a>) with a Overweight and raises the price target from $310 to $390.

CVNA

Wells Fargo Maintains Overweight on Carvana, Raises Price Target to $390

Shares of Blaize Holdings Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BZAI#NASDAQ">BZAI</a>) are soaring Friday afternoon following the announcement of a landmark collaboration with Starshine Computing Power Technology, an Asian AI infrastructure provider. The agreement carries a minimum value of $120 million over its initial 18-month term.
What To Know: The <a href="https://www.benzinga.com/pressreleases/25/07/b46480456/blaize-secures-contract-to-deliver-scalable-hybrid-ai-infrastructure-across-asia">partnership</a> will deploy Blaize&#8217;s hybrid AI platform across Asia, beginning in fiscal the third-quarter of 2025. The initiative targets the rapidly growing demand for real-time, localized AI solutions to power smart cities, industrial automation and intelligent public services. The initial focus will be on smart city applications in key countries, including India, Indonesia, Japan, South Korea and China.
Blaize CEO Dinakar Munagala <a href="https://www.benzinga.com/pressreleases/25/07/b46480456/blaize-secures-contract-to-deliver-scalable-hybrid-ai-infrastructure-across-asia">called</a> the venture &#8220;the beginning of real-world AI infrastructure at scale,&#8221; pointing to Asia&#8217;s $112 billion market for intelligent systems. The collaboration will leverage Blaize's energy-efficient Graph Streaming Processor technology to complement existing GPU-based infrastructure. 
The company says this hybrid approach aims to significantly lower energy consumption and total ownership costs while enabling real-time edge processing for surveillance, manufacturing and AgTech. 
Starshine Chairman Teng Ma praised Blaize&#8217;s platform for its ability to meet the &#8220;surging demand across Asia for real-time, localized intelligence.&#8221;
Price Action: According to data from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>, BZAI shares are trading higher by 70% to $5.15 Friday afternoon. The stock has a 52-week high of $19.25 and a 52-week low of $1.70.
Read Also: <a href="https://www.benzinga.com/trading-ideas/movers/25/07/46494422/draganfly-dpro-stock-plummets-on-25m-offering-what-investors-need-to-know">Draganfly Stock Plummets On $25M Offering: What Investors Need To Know</a>
<h2 class="wp-block-heading">How To Buy BZAI Stock</h2>
Besides going to a brokerage platform to purchase a share &#8211; or fractional share &#8211; of stock, you can also gain access to shares either by buying an exchange traded fund (ETF) that holds the stock itself, or by allocating yourself to a strategy in your 401(k) that would seek to acquire shares in a mutual fund or other instrument. 
For example, in Blaize Holdings&#8217; case, it is in the Information Technology sector. An ETF will likely hold shares in many liquid and large companies that help track that sector, allowing an investor to gain exposure to the trends within that segment.

BZAI

Blaize (BZAI) Stock Surges On $120 Million Asian AI Infrastructure Deal

Wells Fargo analyst Gabe Hajde maintains Silgan Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SLGN#NYSE">SLGN</a>) with a Overweight and raises the price target from $60 to $62.

SLGN

Wells Fargo Maintains Overweight on Silgan Hldgs, Raises Price Target to $62

Wells Fargo analyst Gabe Hajde maintains Sealed Air (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SEE#NYSE">SEE</a>) with a Overweight and raises the price target from $39 to $43.

Wells Fargo Maintains Overweight on Sealed Air, Raises Price Target to $43

"Throw yourself in with zealous passion," Etsy Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ETSY#NASDAQ">ETSY</a>) CEO Josh Silverman told Pace University graduates during a <a href="https://www.youtube.com/watch?v=9JRKNEPUifM">commencement speech</a> in May 19. Silverman urged graduates to find work they enjoy. He said over-delivering on every task sparks career-launching opportunities for today's most ambitious new hires.
<h2 class="wp-block-heading">AI Reshapes Early Careers</h2>
"For me, the most important thing has always been to start by throwing myself in with zealous passion to something that I liked," Silverman said, recounting how failed auditions at Brown University—where he majored in theater— pushed him toward public policy.
Payrolls grew by 147,000 jobs in June and the <a href="https://www.bls.gov/news.release/empsit.nr0.htm?utm">unemployment rate</a> slipped to 4.1%, the Bureau of Labor Statistics reported. Meanwhile, recent <a href="https://www.newyorkfed.org/research/college-labor-market?#--:explore:unemployment">college graduates</a>—those aged 22 to 27—faced a jobless rate of 5.8% in early 2025, significantly higher than the general fourth-quarter average.
Don't Miss:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/money/mode-mobile-accredited-investor-offer">Accredited investors can claim pre-IPO shares of Mode Mobile for just $0.30</a>—with up to 120% bonus shares—before this Uber-style disruption hits the public markets</li>
<li>Named a TIME Best Invention and Backed by 5,000+ Users, Kara's Air-to-Water Pod Cuts Plastic and Costs — <a href="https://www.benzinga.com/money/americans-spend-1000-per-year-on-plastic-water-bottles-kara-pod-gives-you-clean-drinking-water-by-pulling-moisture-from-the-air">And You Can Invest At Just $6.37/Share</a></li>
</ul>
Artificial intelligence is adding pressure. A May <a href="https://www.nber.org/papers/w33867">National Bureau of Economic Research</a> paper found that generative AI eventually displaces workers when wage renegotiation fails, though it boosts short-term productivity.&nbsp;
The World Economic Forum's Future of Jobs Report, released in early January, <a href="https://www.weforum.org/stories/2025/01/future-of-jobs-report-2025-the-fastest-growing-and-declining-jobs/">predicts</a> AI and data processing will create 11 million roles and replace 9 million by 2030.
Gen Z is already adapting. Many are adding micro-credentials instead of waiting on advanced degrees. Enrollments in generative-AI courses jumped 866% year over year, according to <a href="https://www.coursera.org/skills-reports/job-skills">Coursera</a>. Employers are responding with stipends for upskilling, a trend Coursera <a href="https://www.coursera.org/articles/education-stipend">says </a>improves retention and closes skill gaps.&nbsp;
"I was an absolute sponge in meetings. I hung out by the water cooler, determined not to miss the most interesting conversations," Silverman said.&nbsp;
Trending: $100k+ in investable assets? <a href="https://www.benzinga.com/money/wiseradvisor-retirement-planning">Match with a fiduciary advisor for free to learn how you can maximize your retirement and save on taxes</a> – no cost, no obligation.
"Then life opened a totally unexpected door." That door led from answering phones for former Sen. Bill Bradley (D-NJ) after graduating from Brown University. Three years later, Bradley's chief of staff offered him a job at a boutique consulting firm. Silverman said the experience proved that "small rooms often lead to big doors."
"Life shouldn't be full of adventure—it should be an adventure, and don't let that scare you. Embrace it," Silverman told the graduates. Those doors kept opening for him—he co-founded Evite, steered Skype, led consumer products at American Express (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AXP#NYSE">AXP</a>), and became Etsy's CEO in 2017.
"Sitting here, you may not be able to clearly see the opportunities ahead, but you will seize them, shape them, and even create them," Silverman told graduates. For those stepping into a workforce transformed by <a href="https://www.benzinga.com/startups/24/09/41052368/chinas-alibaba-just-launched-a-wave-of-100-open-source-ai-models-including-a-text-to-video-tool-that">AI</a>, it was his final challenge—and a call to embrace the unknown with confidence.
Read Next:&nbsp;
<ul class="wp-block-list">
<li>This AI-Powered Trading Platform Has 5,000+ Users, 27 Pending Patents, and a $43.97M Valuation — <a href="https://www.benzinga.com/money/finally-a-fully-automated-trading-platform-for-individual-investors?">You Can Become an Investor for Just $500.25</a></li>
<li>Warren Buffett once said, "If you don't find a way to make money while you sleep, you will work until you die."<a href="https://www.benzinga.com/money/warren-buffet-make-money-when-you-sleep"> Here&#8217;s how you can earn passive income with just $10.</a></li>
</ul>
Image: Shutterstock

ETSY

'Throw Yourself In With Zealous Passion,' Says Etsy CEO Josh Silverman, Who Went From Theater Major To Running A $5.3 Billion Company

Wells Fargo analyst Gabe Hajde maintains Magnera (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MAGN#NYSE">MAGN</a>) with a Equal-Weight and lowers the price target from $16 to $14.

MAGN

Wells Fargo Maintains Equal-Weight on Magnera, Lowers Price Target to $14

Wells Fargo analyst Gabe Hajde maintains Graphic Packaging Holding (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GPK#NYSE">GPK</a>) with a Equal-Weight and raises the price target from $21 to $23.

Wells Fargo Maintains Equal-Weight on Graphic Packaging Holding, Raises Price Target to $23

Press Releases

Clearside Biomedical Announces Six Abstracts Accepted for Presentation at Association for Research in Vision and Ophthalmology (ARVO) 2025 Meeting

Earnings

Clearside Biomedical Announces Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update

Clearside Biomedical to Participate in a Fireside Chat at the 24th Annual Needham Virtual Healthcare Conference

Health Care

Clearside Biomedical to Participate in a Fireside Chat at the Citizens Life Sciences Conference

Clearside Biomedical to Report First Quarter 2025 Financial Results on Wednesday, May 14, 2025

Clearside Biomedical Data Featured in Six Presentations at Association for Research in Vision and Ophthalmology (ARVO) 2025 Meeting

Clearside Biomedical Announces First Quarter 2025 Financial Results and Provides Corporate Update

Clearside Biomedical to Participate in a Fireside Chat at the Stifel 2025 Virtual Ophthalmology Forum

Clearside Biomedical Announces Multiple Presentations to be Featured at the Clinical Trials at the Summit Meeting

General

Clearside Biomedical Announces Plan to Explore Strategic Alternatives to Advance its Proprietary Suprachoroidal Space (SCS®) Delivery Platform and Promising Ophthalmology Pipeline

CLSD

Anebulo Pharmaceuticals, Inc. - Common Stock

Anebulo Pharmaceuticals

Alto Neuroscience

AN2 Therapeutics

Assertio Holdings

CalciMedica

Cognition Therapeutics, Inc. - Common Stock

Cognition Therapeutics

Clearside Biomedical, Inc. - Common Stock

Cumberland Pharmaceuticals Inc. - Common Stock

Cumberland

Cadrenal Therapeutics, Inc. - Common Stock

Cadrenal Therapeutics

Dare Bioscience

Grace Therapeutics

Hyperion DeFi

IGC Pharma

Ikena Oncology

Iterum Therapeutics

Jupiter Neurosciences, Inc. - Common Stock

Jupiter Neurosciences

MIRA Pharmaceuticals, Inc. - Common Stock

Mira Pharmaceuticals

NRX Pharmaceuticals

Pulmatrix

Rafael Holdings, Inc. Class B Common Stock

Rafael Holdings

Reviva Pharmaceuticals Holdings, Inc. - Common Stock

Reviva Pharmaceuticals

Scilex Holding

SCYNEXIS

Telomir Pharmaceuticals, Inc. - Common Stock

Telomir Pharmaceuticals

Universe Pharmaceuticals Inc - Ordinary Shares

Universe Pharmaceuticals

Verrica Pharmaceuticals Inc. - Common Stock

Verrica Pharmaceuticals

HC Wainwright & Co.

Needham

JMP Securities

Citizens Capital Markets

Oppenheimer

Clearside Biomedical shares are trading lower after HC Wainwright & Co downgraded the stock from Buy to Neutral. Also, Chardan Capital downgraded the stock from Buy to Neutral.

Comments

Clearside Biomedical

Clearside Biomedical (CLSD) Options

Clearside Biomedical (NASDAQ:CLSD) Stock, Chaîne d'Options

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL